Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T11824L |
Lanraplenib monosuccinate
GS-9876 monosuccinate |
Syk | Angiogenesis; Tyrosine Kinase/Adaptors |
Lanraplenib monosuccinate inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding time (BT) in monkeys or humans. Lanraplenib monosuccinate is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treatment of inflammatory diseases. | |||
T11824 |
Lanraplenib succinate
GS-9876 succinate |
Syk | Angiogenesis; Tyrosine Kinase/Adaptors |
Lanraplenib succinate inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding time (BT) in monkeys or humans. Lanraplenib succinate is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treatment of inflammatory diseases. | |||
T11824LL |
Lanraplenib
GS-9876 |
Syk | Angiogenesis; Tyrosine Kinase/Adaptors |
Lanraplenib (GS-9876) 是高效的、选择性的、口服具有活力的 SYK 抑制剂 (IC50=9.5 nM) ,能够用于炎症性疾病的研究。它通过糖蛋白 VI (GPVI) 受体抑制血小板中的 SYK 活性,而不会延长猴子或人类的出血时间 (BT)。 |